ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 279 filers reported holding ACADIA PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 0.89 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $4,375,566 | -87.5% | 209,960 | -67.9% | 0.85% | -65.4% |
Q4 2020 | $34,985,000 | +52.4% | 654,414 | +17.6% | 2.46% | +24.9% |
Q3 2020 | $22,956,000 | +38.2% | 556,514 | +62.4% | 1.97% | +29.4% |
Q2 2020 | $16,609,000 | +65.6% | 342,663 | +44.3% | 1.52% | -20.8% |
Q1 2020 | $10,032,000 | +62.3% | 237,450 | +64.4% | 1.93% | +108.9% |
Q4 2019 | $6,180,000 | -64.9% | 144,450 | -81.6% | 0.92% | -52.2% |
Q1 2018 | $17,604,000 | -48.3% | 783,424 | -30.8% | 1.93% | -54.7% |
Q4 2017 | $34,076,000 | +10.0% | 1,131,722 | +37.6% | 4.26% | +6.7% |
Q3 2017 | $30,980,000 | +1.1% | 822,392 | -25.2% | 3.99% | +19.1% |
Q2 2017 | $30,646,000 | +32.8% | 1,098,809 | +63.7% | 3.35% | +24.3% |
Q1 2017 | $23,073,000 | -32.0% | 671,113 | -43.0% | 2.70% | -28.3% |
Q4 2016 | $33,932,000 | +1808.4% | 1,176,543 | +2004.8% | 3.76% | +2048.0% |
Q3 2016 | $1,778,000 | +85.2% | 55,897 | +89.0% | 0.18% | +76.8% |
Q2 2016 | $960,000 | -95.0% | 29,582 | -95.7% | 0.10% | -89.4% |
Q1 2016 | $19,312,000 | – | 690,700 | – | 0.93% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Baker Brothers Advisors | 28,439,114 | $590,396,000 | 3.89% |
GREAT POINT PARTNERS LLC | 1,196,098 | $24,831,000 | 3.87% |
EMORY UNIVERSITY | 196,601 | $4,081,000 | 2.67% |
Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
NEXTHERA CAPITAL LP | 500,000 | $10,380,000 | 1.99% |
Palo Alto Investors LP | 1,684,180 | $34,964,000 | 1.41% |
Opus Point Partners Management, LLC | 20,828 | $432,000 | 1.03% |
Opaleye Management Inc. | 195,000 | $4,048,000 | 1.03% |
GARRISON BRADFORD & ASSOCIATES INC | 48,500 | $1,007,000 | 0.81% |